Pyxis Oncology annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Pyxis Oncology Capital Expenditures (CapEx) Growth & History (PYXS)
Pyxis Oncology's capital expenditures (capex) was $9,000 for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9,000 | −$228,000 | −96.20% |
| 2024 | 2024-12-31 | $237,000 | −$6.5M | −96.48% |
| 2023 | 2023-12-31 | $6.7M | $327,000 | +5.11% |
| 2022 | 2022-12-31 | $6.4M | $5.9M | +1085.00% |
| 2021 | 2021-12-31 | $540,000 | −$943,000 | −63.59% |
| 2020 | 2020-12-31 | $1.5M | — | — |
Pyxis Oncology quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | −$61,000 | — |
| Q2 2024 | 2024-06-30 | $0 | −$2.3M | — |
| Q1 2024 | 2024-03-31 | $237,000 | −$4.2M | −94.62% |
| Q4 2023 | 2023-12-31 | $0 | −$1.9M | — |
| Q3 2023 | 2023-09-30 | $61,000 | −$4.2M | −98.57% |
| Q2 2023 | 2023-06-30 | $2.3M | $2.1M | +1651.16% |
| Q1 2023 | 2023-03-31 | $4.4M | $4.3M | +2917.81% |
| Q4 2022 | 2022-12-31 | $1.9M | $1.9M | — |
| Q3 2022 | 2022-09-30 | $4.3M | $4.3M | — |
| Q2 2022 | 2022-06-30 | $129,000 | −$242,000 | −65.23% |
| Q1 2022 | 2022-03-31 | $146,000 | −$23,000 | −13.61% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $371,000 | — | — |
| Q1 2021 | 2021-03-31 | $169,000 | — | — |
Pyxis Oncology capital expenditures (capex) trends
Over the last five fiscal years, Pyxis Oncology's capital expenditures (capex) decreased from $1.5M to $9,000, a change of −$1.5M. The latest reported quarter, Q4 2024, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗